Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sanofi Pasteur, the vaccines division of Sanofi-Aventis Group, has announced that Russia has chosen the company's inactivated polio vaccine for primary immunization of all infants.
Subscribe to our email newsletter
The inactivated polio vaccine (IPV) doses are provided by MP Chumakov Institute of Poliomyelitis and Virus Encephalitides through a manufacturing agreement with Sanofi Pasteur.
The Russian Federation was certified polio-free in 2002. Since 2006, children from certain at risk groups are vaccinated with IPV. Starting mid 2008, all children less than one year of age are vaccinated following a sequential schedule – three doses of IPV for primary immunization, followed by two doses of oral polio vaccine, the company said.
Sergey Drosdov, senior scientific advisor of MP Chumakov Institute of Poliomyelitis and Viral Encephalitides Russian Academy Medical Sciences, said: “The Chumakov Institute was the first to produce oral polio vaccine which was instrumental in eradicating poliomyelitis in Russia. Today, IPV is the vaccine of choice for post-eradication polio immunization programs and the Institute is proud to bring this vaccine to Russian children.”